TBA
AMPE

Thomas B. Akin’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Thomas B. Akin’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$9.62M Buy
+4,277
New +$8.27M 7.43% 6

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Thomas B. Akin's AMPE Position: Q3 2013 in Review

Thomas B. Akin opened a new position in Ampio Pharmaceuticals Inc. (AMPE) in Q3 2013: 4,277 shares worth $9.62M. The stake represents 7.43% of the portfolio and ranks #6 among its holdings.

60 funds tracked by Wall St. Rank hold AMPE as of Q3 2013.

  • Thomas B. Akin held 4,277 shares of Ampio Pharmaceuticals Inc. worth $9.62M as of Q3 2013.
  • Ampio Pharmaceuticals Inc. was a new Thomas B. Akin position in Q3 2013.
  • Ampio Pharmaceuticals Inc. made up 7.43% of Thomas B. Akin's portfolio in Q3 2013, its #6 holding.
  • 60 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2013.

Based on Thomas B. Akin's 13F filing for Q3 2013, filed 13 Nov 2013.